Page 90 - 4PDF Alin Dexametasona flipbook

DEXAMETASONA EN INMUNOLOGÍA Y ALERGIA

Bibliografía

– Maurer M, Church M, Goncalo M, et al. Management and treatment
of chornic urticarial (CU). JEADV 2015, 29 (Suppl. 3) 16-32.Euro-
pean Academy of Dermatology and Venereology.
– Magerl M, Borzova E, Gimenez-Arnau A, Et al. The definition and
diagnostic testing of physical and cholinergic urticarias—EAACI/
GA2LEN/EDF/UNEV consensus panel recommendations.
– Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy
Clin Immunol. 2004;114(3):465.
– Mims JW. Advancements and dilemmas in the management of allergy.
Otolaryngol N Am 50 (2017); 1037-1042.
– Jiménez-Saab N. Anafilaxia En Pliego-Reyes C y Cabrera-Rayo A.
Puesta al día en medicina interna. Temas de inmunología y alergias.
Editorial Alfil. México, D.F. 2011: 161-170.
– Seghezzo S, Arnold D, Gay J, Moore P, Johnson D. Dexamethasone for
inpatient childhood asthma exacerbations is as effective as short-acting
corticosteroid treatment. Annals of Allergy, Asthma & Immunol 2018,
120(1): 94-95.
– Chang YL, Jian KR, Lin CS, Wang HW, Liu SC. Dexamethasone
attenuates methacholine-mediated aquaporin 5 downregulation in
human nasal epithelial cell via suppression of NF-kB activation. Int
Forum Allergy Rhinol. 2018 Jan;8(1):64-71.
– Chen FC, Wang LH, Zheng XY, Zhang XM, Zhang J, Li LJ. Me-
ta-analysis of the effectsof oral and intravenous dexamethasone pre-
medication in the prevention of paclitaxel-induced allergic reactions.
Oncotarget. 2017 Mar 21;8(12):19236-19243.
– Sánchez-Hernández MC, Montero J, Rondon C, Benítez del Castillo
JM, Velázquez E, et al. Consensus document on allergic conjunctivitis
(DECA). J Investig Allergol Clin Immunol. 2015; 25(2):94-106.

89